Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Colorectal Dis. 2020 Jan;22(1):62-70. doi: 10.1111/codi.14793. Epub 2019 Nov 12.
Patient body composition is an important indicator of metabolic status and is associated with cancer progression. Because body composition varies between men and women, we aimed to examine the difference in clinical impact of preoperative body composition according to sex.
We used an integrated dataset of 559 colorectal cancer (CRC) patients. The association between preoperative body composition indices [body mass index (BMI), visceral to subcutaneous fat area ratio (VSR) and skeletal muscle index (SMI)] and patient outcome, clinicopathological factors and preoperative inflammation and nutritional status was analysed, comparing men and women.
Preoperative low BMI and low SMI in men was significantly associated with unfavourable overall survival (OS) [BMI: hazard ratio (HR) 2.22, 95% CI 1.28-4.14, P = 0.004; SMI: HR 2.54, 95% CI 1.61-4.07, P < 0.001] and high VSR in women was significantly associated with unfavourable OS (HR 1.79, 95% CI 1.03-3.02, P = 0.040). Additionally, low SMI in men was significantly associated with deeper tumour invasion and greater distant metastasis and high VSR in women was significantly associated with advanced age, right-sided tumour, lower total lymphocyte count and lower albumin levels. Interestingly, low BMI in men was significantly associated with deeper tumour invasion, but also with favourable inflammation and nutritional status (lower C-reactive protein and higher albumin).
The clinical impact of preoperative body composition differed between men and women: SMI in men and VSR in women were good prognosticators. Our findings may provide a novel insight for CRC treatment strategies.
患者的身体成分是代谢状态的一个重要指标,与癌症的进展有关。由于男性和女性的身体成分不同,我们旨在检查根据性别术前身体成分的临床影响差异。
我们使用了 559 例结直肠癌(CRC)患者的综合数据集。分析了术前身体成分指标(体重指数[BMI]、内脏到皮下脂肪面积比[VSR]和骨骼肌指数[SMI])与患者预后、临床病理因素以及术前炎症和营养状况之间的关系,并比较了男性和女性之间的差异。
男性术前低 BMI 和低 SMI 与不良总生存期(OS)显著相关(BMI:风险比[HR]2.22,95%CI 1.28-4.14,P=0.004;SMI:HR 2.54,95%CI 1.61-4.07,P<0.001),女性高 VSR 与不良 OS 显著相关(HR 1.79,95%CI 1.03-3.02,P=0.040)。此外,男性低 SMI 与肿瘤浸润更深、远处转移更多有关,而女性高 VSR 与年龄较大、右侧肿瘤、总淋巴细胞计数较低和白蛋白水平较低有关。有趣的是,男性低 BMI 与肿瘤浸润更深有关,但也与炎症和营养状况良好有关(C 反应蛋白较低,白蛋白较高)。
术前身体成分的临床影响在男性和女性之间存在差异:男性的 SMI 和女性的 VSR 是良好的预后指标。我们的发现可能为 CRC 治疗策略提供新的见解。